In addition to hyperactivate the TGF‐β signalling, CAF‐sEVs potentiate the aggressiveness of highly invasive breast cancer cells and enable a similar behaviour in otherwise poorly invasive breast cancer cells. The gene discussed is TGFB1; the disease is breast cancer.